Ambalal Sarabhai Enterprises Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

57.15

-2.42 (-4.06%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

57.15

-2.42 (-4.06%)
16:01 Dec 20

Quality

62/100
High Financial Strength

Valuation

47/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	163.64	196.75	170.28	173.57	182.86
Operating Expenses +	165.43	171.85	161.71	167.25	171.21
Raw Material	98.39	114.07	105.24	98.62	104.53
Increase Decrease in Cost	1.58	0.64	-2.38	2.4	-2.85
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	28.2	25.3	25.33	27.7	29.36
Miscellaneous Expenses	209.82	234.52	217.84	205.35	40.17
Operating Profit	-1.79	24.9	8.57	6.32	11.65
Other Income	30.58	42.02	12.49	10.37	10.29
Depreciation	2.41	2.32	2.76	3.57	3.37
Interest	2.95	1.7	2.44	3.76	4.06
Profit before tax and exceptio..	23.43	62.89	15.87	9.36	14.51
Exceptional Items	0	-15.11	0	0	0
PBT	23.43	47.77	15.87	9.36	14.51
Provision for Taxation	3.19	6.98	3.72	0.97	0.96
Net Profit	20.24	40.8	12.14	8.39	13.54
NET Profit after MI	29.36	47.22	11.1	5.68	13.17
EPS	3.83	6.16	1.45	0.74	1.72
Operating Profit Margin (%)	-1.09	12.66	5.03	3.64	6.37
Net Profit Margin (%)	17.94	24	6.52	3.27	7.2

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	31.40	30.80	30.80	30.80	30.80
FII	0.00	0.00	0.00	0.00	0.00
MF	0.00	0.00	0.00	0.00	0.00
Public	68.60	69.20	69.20	69.20	69.20
Others	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	0.00	0.00	0.00